Skip to main content

Advertisement

Table 1 Blood parameters and patient demographic. SF-36 scores were analysed using participant questionnaire responses. Results from routine full blood analysis in CFS/ME patients and HC

From: Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients

  CFS/ME HC P Value
Age (years) 42.5 ± 3.5 43.5 ± 3.9 0.699
Gender n(%)
 Male 1 1 1.000
 Female 5 5  
 BMI (kg/m2) 24.04 ± 0.74 23.8 ± 1.46 0.589
WHODAS 47.4 ± 6.47 4.34 ± 3.68 0.002
SF-36
 General Health (%) 28.47 ± 5.63 75.69 ± 3.3 0.002
 Physical Functioning (%) 35.83 ± 8.89 95.83 ± 1.54 0.002
 Role Physical (%) 5.27 ± 4.09 97.92 ± 2.08 0.002
 Role Emotional (%) 70.48 ± 15.32 100 ± 0 0.180
 Social Functioning (%) 35.42 ± 13.85 98 ± 2 0.030
 Body Pain (%) 37 ± 14.12 94.58 ± 2.45 0.004
Pathology
 White Cell Count (× 109/L) 6.18 ± 0.38 6.15 ± 0.51 1.000
 Lymphocytes (× 109/L) 2.11 ± 0.22 1.85 ± 0.10 0.132
 Neutrophils (× 109/L) 3.24 ± 0.28 3.62 ± 0.10 0.589
 Monocytes (× 109/L) 0.52 ± 0.03 0.48 ± 0.08 0.699
 Eosinophils (× 109/L) 0.26 ± 0.10 0.15 ± 0.03 0.394
 Basophils (× 109/L) 0.05 ± 0.01 0.05 ± 0.01 0.937
 Platelet (× 109/L) 237 ± 8.99 269.33 ± 16.64 0.180
 Red Cell Count (× 1012/L) 4.49 ± 0.17 4.80 ± 0.31 0.485
 Haematocrit 0.40 ± 0.01 0.42 ± 0.02 0.394
 Haemoglobin (g/L) 137.17 ± 5.88 140.83 ± 5.17 0.485
  1. Data presented as mean ± SEM. Abbreviations: CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis; HC, healthy controls; BMI, body mass index; WHODAS: World Health Organization Disability Assessment Schedule